Metastatic bone disease and the role of biochemical markers of bone metabolism in benign and malignant diseases

Cancer Treatment Reviews

Volumn 27, Issue 3, 2001, Pages 133-135

  Coleman, R E ^a  

^a WESTON PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; PYRIDINOLINE;

AMINO TERMINAL SEQUENCE; BENIGN TUMOR; BIOCHEMISTRY; BIOLOGY; BONE DISEASE; BONE METABOLISM; BONE METASTASIS; BREAST CANCER; CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; DRUG RESPONSE; EDITORIAL; ENDOCRINOLOGY; HORMONAL THERAPY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; ONCOLOGY; OSSIFICATION; OSTEOLYSIS; PREDICTION; PROGNOSIS; PROSTATE CANCER; SWITZERLAND; SYMPOSIUM;

EID: 0035022117     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1053/ctrv.2000.0206     Document Type: Editorial

References (8)

1. Yoneda T., Michigami T., Yi B. Use of bisphosphonates for the treatment of bone metastasis in experimental animal models. Cancer Treat Rev. 25:1999;293-299.
2. Powles T. J., Paterson A. H. G., Nevantaus A. Adjuvant clodronate reduces the incidence of bone metastases in patients with primary operable breast cancer. ASCO Proc. 17:1998;468a.
3. Diel I., Solomayer E-F., Costa S. J. Reduction in new metastases in breast cancer with adjuvant clodronate treatment. N Engl J Med. 339:1998;357-363.
4. Colleoni M., O'Neill A., Goldhirsch A. Identifying breast cancer patients at high risk for bone metastases. J Clin Oncol. 23:2000;3925-3935.
5. Hayward I. L., Carbone P. P., Heusen J. C. Assessment of response to therapy in advanced breast cancer. 1977;. p. 292-298.
6. Coleman R. E. Rubens RD, Mundy GR (eds), Biochemical markers of malignant bone disease. 2000;Martin ; Dunitz, London. p. 137-150.
7. Hannon R., Blumshohn A., Naylor K., Eastell R. Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability. J Bone Miner Res. 13:1998;1124-1133.
8. Garnero P., Grimaux M., Demiaux B., Preaudat C., Sequin P., Delmas P. D. Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay. J Bone Miner Res. 7:1992;1389-1398.